New scan may spot brain tumor recurrence without surgery
NCT ID NCT06444412
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special PET scan using GA-68 PSMA-11 can tell the difference between a returning brain tumor and changes caused by previous treatment. About 25 adults with grade 3 or 4 glioma who are already scheduled for surgery will receive the scan beforehand. If successful, this imaging method could reduce the need for invasive biopsies and help doctors make faster, more accurate treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WHO GRADE 3 GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Promising drug combo targets aggressive brain cancers in youth
- Brain radiation showdown: proton vs. photon – which saves your mind?
- New hope for kids with deadly brain cancer: targeted drug trial launches
- New drug combo shows promise for kids with aggressive brain tumors
- Engineered immune cells take on recurrent brain tumors in early trial
- Targeted drug shows promise for Hard-to-Treat brain and bile duct cancers